Occurrence of vitiligo in a patient with ankylosing spondylitis receiving adalimumab

被引：8
|
作者：
Toussirot, E. [1 ,2 ,3 ,4 ]
Salard, D. [5 ]
Algros, M. -P. [6 ]
Aubin, F. [7 ,8 ]
机构：
[1] CHRU, Ctr Invest Clin Biotherapie, Pole Rech, Inserm CBT 506, F-25000 Besancon, France
[2] Hop Jean Minjoz, CHRU, Pole PACTE, F-25000 Besancon, France
[3] Univ Franche Comte, Dept Univ Therapeut, F-25000 Besancon, France
[4] Univ Franche Comte, UPRES EA Agents Pathogenes & Inflammat 4266, SFR FED 4234, F-25000 Besancon, France
[5] Ctr Hosp, Serv Med 1, F-25300 Pontarlier, France
[6] Hop Jean Minjoz, CHRU, Serv Anat Pathol, F-25030 Besancon, France
[7] Hop Jean Minjoz, CHRU, Serv Dermatol, F-25030 Besancon, France
[8] Univ Franche Comte, Equipe Accueil EA3181, SFR FED 4234, F-25000 Besancon, France
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2013年 / 140卷 / 12期
关键词：
NECROSIS-FACTOR-ALPHA;
D O I：
10.1016/j.annder.2013.09.158
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：801 / 802
页数：2
相关论文
共 50 条
  • [31] THE FAMILIAL OCCURRENCE OF ANKYLOSING SPONDYLITIS
    JACOBS, JH
    ROSE, FC
    BMJ-BRITISH MEDICAL JOURNAL, 1954, 2 (4897): : 1139 - 1140
  • [32] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baynton, E.
    VALUE IN HEALTH, 2014, 17 (07) : A522 - A523
  • [33] A Case of Adalimumab-Induced Psoriasiform Dermatitis in an Ankylosing Spondylitis Patient: Unusual Progression after Adalimumab Retreatment
    Yoon, Ji Ha
    Jung, Joon Woo
    Park, Eun Joo
    Kim, Kwang Joong
    Kim, Kwang Ho
    ANNALS OF DERMATOLOGY, 2022, 34 (05) : 396 - 398
  • [34] Real-life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
    Kapoor, Sanjiv
    Kaushik, Viswanath V.
    Jain, Rahul
    Rao, Vijay K. R.
    Gharia, Mihir
    ACR OPEN RHEUMATOLOGY, 2019, 1 (08) : 480 - 484
  • [35] Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab
    Choquette, Denis
    Bessette, Louis
    Raynauld, Jean-Pierre
    Pelletier, Jean-Pierre
    Haraoui, Boulos
    Villeneuve, Edith
    Massicotte, Frederic
    Remillard, Marie-Anais
    Sauvageau, Diane
    Coupal, Louis
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1345 - 1345
  • [36] Rapid recurrence of dermatofibrosarcoma protuberans after initiation of adalimumab therapy in a patient with ankylosing spondylitis
    Hayama, Koremasa
    Fujita, Hideki
    Fujimaki, Mitsue
    Takahashi, Shogo
    Yoshida, Yukihiro
    Nozaki, Takamasa
    Terui, Tadashi
    JOURNAL OF DERMATOLOGY, 2020, 47 (06): : E244 - E246
  • [37] Successful treatment with adalimumab in a patient with coexisting Beh‡et's disease and ankylosing spondylitis
    Yildiz, Necmettin
    Alkan, Hakan
    Ardic, Fusun
    Topuz, Oya
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (11) : 1511 - 1514
  • [38] Successful treatment with adalimumab in a patient with coexisting Behçet’s disease and ankylosing spondylitis
    Necmettin Yildiz
    Hakan Alkan
    Fusun Ardic
    Oya Topuz
    Rheumatology International, 2010, 30 : 1511 - 1514
  • [39] Intestinal Behcet's disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis
    Chung, Sook Hee
    Park, Soo Jung
    Hong, Sung Pil
    Cheon, Jae Hee
    Kim, Tae Il
    Kim, Won Ho
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (32) : 5389 - 5392
  • [40] Occurrence of fibromyalgia in patients with ankylosing spondylitis
    Azevedo, Valderilio Feijo
    Paiva, Eduardo dos Santos
    Hiurko Felippe, Lucio Ricardo
    Moreira, Ranieri Amorim
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2010, 50 (06) : 650 - 654
12345